US 11013782
Methods of treating chronic disorders with complement inhibitors
granted A61KA61K31/7088A61K31/7105
Quick answer
US patent 11013782 (Methods of treating chronic disorders with complement inhibitors) held by Apellis Pharmaceuticals, Inc. expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/7088, A61K31/7105, A61K38/10, A61K38/12